This is in contrast, however, to the situation in the 4 repeat tau condition of CBD, where studies using [18F]flortaucipir have shown a binding clearly different from that in controls, corresponding to affected areas, also at neuropathology [14, 32, 52, 53]. This evidence concerns the gene MAPT and red-green color blindness.